stella
beta
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN — Stella
Home
/
Hepatocellular Carcinoma (HCC)
/
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN
View on ClinicalTrials.gov
Recruiting
Back to Hepatocellular Carcinoma (HCC) trials
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NEN
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
France
CHU de Nantes, Nantes
AP-HP - Site de Beaujon, Paris